In today’s volatile cannabis market, innovation has never been more essential or more difficult to sustain. While scientific breakthroughs in formulations, delivery systems, and cannabinoids continue to emerge, many never reach consumers. Market forces favoring low-cost, high-THC products, combined with regulatory complexity and capital constraints, deprioritize long-term innovation in favor of short-term survival.

This panel brings together leaders across science, capital, and business to explore how companies are finding ways forward and bridging the gap between breakthrough ideas and sustainable market success. Panelists will share strategies for navigating financial and operational barriers, building resilience in a constrained capital environment, and leading innovation in an industry where volatility is the norm.